Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 2, 2003, Pages 203-209

  Gardner, Lytt I ^a,g   Holmberg, Scott D ^a   Williamson, John M ^a   Szczech, Lynda A ^b   Carpenter, Charles C J ^c   Rompalo, Anne M ^d   Schuman, Paula ^e   Klein, Robert S ^f  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c BROWN UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Associated renal abnormalities; HIV; HIV and women; HIV epidemiology; HIV associated nephropathy

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMMUNITY CARE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH CERTIFICATE; DISEASE COURSE; FEMALE; HEALTH HAZARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MEDICAL RECORD; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; STATISTICAL SIGNIFICANCE; UNITED STATES; URBAN AREA;

EID: 0037321542     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200302010-00013     Document Type: Article

References (29)

1. Rao TKS, Filippone EJ, Nicastri AD, et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984;310:669-73.
2. Pardo V, Aldana M, Colton RM, et al. Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 1984;101: 429-34.
3. Kimmel PL. Clinical and immunopathogenic aspects of human immunodeficiency virus-associated renal diseases. In Neilson EG, Couser WG, eds. Immunologic renal diseases. New York: Lippincott-Raven, 1997:1181-97.
4. Szczech LA. Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management. Clin Infect Dis 2001;33:115-9.
5. Stokes MV, Chawla H, Brody RI, et al. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am J Kidney Dis 1997;29:515-25.
6. Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 1999;55:1036-40.
7. Perinbasakar D, Brod-Miller C, Somnath P, et al. Predictors of survival in HIV-infected patients on hemodialysis. Am J Nephrol 1996; 16:280-6.
8. Ortiz C, Meneses R, Jaffe D, et al. Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int 1988;44:373-8.
9. Kimmel PL, Umana WO, Simmens SJ, et al. Continuous ambulatory peritoneal dialysis and survival of HIV-infected patients with end-stage renal disease. Kidney Int 1993;44:373-8.
10. Smith DK, Warren DL, Vlahov D, et al. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in U.S. women. Am J Epidemiol 1997;146:459-70.
11. Thomas DL, Rich J, Schuman P, et al., for the HER Study Group. Multicenter evaluation of hepatitis C RNA levels among female injecting drug users. J Infect Dis 2001;183:973-6.
12. Giorgi J, Cheng H, Margolick J, et al. Quality control in the flow cytometric measurement of T-lymphocyte subsets: The Multicenter AIDS Cohort Study (MACS) experience. Clin Immunol Immunopathol 1990;55:173-86.
13. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41.
14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
15. Panel on Clinical Practices for the Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Foundation, January 28, 2000. Available at: http://www.hivatis.org/guidelines/AA599.pdf.
16. Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax nationwide death search. Am J Epidemiol 1994;140:1016-178.
17. Edlavitch SA, Baxter J. Comparability of mortality follow-up before and after the National Death Index. Am J Epidemiol 1988; 127:1164-78.
18. Cox DR. Regression models and life-tables. J R Stat Soc Series B 1972;34:187-220.
19. Chemlal K, Nochy D, Kenouch S, et al. Dramatic improvement of renal dysfunction in a human immunodeficiency virus-infected woman treated with highly active antiretroviral therapy. Clin Infect Dis 2000;31:805-6.
20. Wali RK, Drachenberg CI, Papadimitriou DC, et al. HIV-1- associated nephropathy and response to highly active antiretroviral therapy. Lancet 1998;352:783-4.
21. Bjorck S, Meyer T, et al. Renal protective effects of enalapril in diabetic nephropathy. BMJ 1992;304:339-43.
22. Lewis EJ, Hunsicker LG, et al. The effect of angiotensin- converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-62.
23. Maschio G, Alberti A, Janin G, et al. Effect of angiotensin- converting enzyme inhibitor benazepril on the progression of chronic renal dysfunction. N Engl J Med 1996;334:939-45.
24. Bourgoignie JJ. Renal complications of human immunodeficiency virus type 1. Kidney Int 1990;37:1571-84.
25. Cantor ES, Kimmel PL, Bosch JP. Effect of race on expression of acquired immunodeficiency syndrome - associated nephropathy. Arch Intern Med 1991;151:125-8.
26. Winston JA, Burns GC, Klotman PE. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy. Semin Nephrol 1998;18:373-7.
27. Agodoa LY, Appel L, Bakris GL, et al. Effect of ramipril versus amlodipine on renal outcomes in hypertensive nephrosclerosis. JAMA 2001;285:2719-28.
28. Marlink R, Kao H, Hsieh E. Clinical care issues for women living with HIV and AIDS in the United States. AIDS Res Hum Retroviruses 2001;17:1-33.
29. Burns GC, Subik KP, Toth IR, et al. Effect of angiotensin- converting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol 1997;8:1140-6.